logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
T

Thomas Bieber

ludwig-maximilian university of munich

105H指数
884论文数
4.9W被引数
收录论文 412
发表时间
logo
Reassessing the OX40/OX40L axis in atopic dermatitis after the termination of Rocatinlimab's clinical development program重新评估罗卡替利单抗临床开发项目终止后特应性皮炎中的OX40/OX40L轴
errJournal of the European Academy of Dermatology and Venereology
IF8
err2026-08-01
err0
errOAAI
errThomas Bieber
err分享
err收藏
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis阿布罗西替比治疗中重度特应性皮炎的持续开启/关闭治疗疾病控制
errJournal of Dermatological Treatment
IF3.9
err2026-05-21
err0
errOAAI
errEmma Guttman-Yassky; Thomas Bieber; Kenji Kabashima; Jan Gutermuth; Stephan Weidinger; Andreas Wollenberg; Irina Lazariciu; Gerardo Encinas; Marina Mikheil; Melissa Watkins
err分享
err收藏
Letter to the editor submitted in response to ‘Are potential remittive properties of OX-40 inhibitors something to be excited about?’致编辑的信，回应‘OX-40抑制剂潜在的治疗缓解特性是否值得兴奋？’
errJournal of Dermatological Treatment
IF3.9
err2026-04-16
err0
errOAAI
errAndrew Blauvelt; Thomas Bieber; Stephan Weidinger; Raj Chovatiya; Kassim Rahawi
err分享
err收藏
REZPEGALDESLEUKIN, NOVEL TREG-INDUCING THERAPY, DEMONSTRATES EFFICACY IN ATOPIC DERMATITIS AND ASTHMA IN PHASE 2B TRIALREZPEGALDESLEUKIN，一种新型Treg诱导疗法，在2b期临床试验中显示出对特应性皮炎和哮喘的有效性。
errAnnals of Allergy, Asthma & Immunology
IF0
err2025-11-05
err0
PREAI
errJ. Corren; P. Lio; J. Silverberg; R. Chovatiya; M. Gooderham; T. Bieber; R. Warren; N. Sadick; J. Treat; S. Gkalpakiotis; A. Reich; S. Chaudhry; Z. Lee; M. Hannaway; D. Yu; Y. Liu; C. Fanton; M. Zhang; W. Waltz; J. Gilbert; S. Charoenthongtrakul; C. Jue; M. Marcondes; B. Kotzin; M. Tagliaferri; J. Zalevsky; D. Rosmarin
err分享
err收藏
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis特应性皮炎中阿利替尼单抗扩展III期给药方案的群体药代动力学和药效动力学模型预测
errCPT: Pharmacometrics & Systems Pharmacology
IF0
err2025-10-01
err0
errOAAI
errGilles Tiraboschi; Kim Papp; Thomas Bieber; Stephan Weidinger; Lisa Beck; Chih-Hung Lee; John T. O'Malley; Karl Yen; Charlotte Bernigaud; David Fabre; Fabrice Hurbin
err分享
err收藏
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?过敏性合并症是否会影响中度至重度特应性皮炎患者中使用阿布罗西替布或杜匹卢单抗的疗效和安全性？
errDermatology and Therapy
IF4.2
err2025-09-23
err0
errOAAI
errEric L. Simpson; Jonathan I. Silverberg; Bob Geng; José-Manuel Carrascosa; Thomas Bieber; Patrick M. Brunner; Delphine Staumont-Sallé; Chao Ji; Pinaki Biswas; Claire Feeney; Irene Hernández-Martín; Francisco José Rebollo Laserna; Herwig Koppensteiner
err分享
err收藏
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks乌帕替尼（Upadacitinib）治疗中重度特应性皮炎的疗效与安全性：第3期随机临床试验结果（为期140周）
errAmerican Journal of Clinical Dermatology
IF8.8
err2025-09-03
err0
errOAAI
errAlan D. Irvine; Vimal H. Prajapati; Emma Guttman-Yassky; Eric L. Simpson; Kim A. Papp; Andrew Blauvelt; Chia-Yu Chu; H. Chih-ho Hong; Linda F. Stein Gold; Marjolein de Bruin-Weller; Thomas Bieber; Kenji Kabashima; David Rosmarin; Cristina Sancho; Brian M. Calimlim; Ayman Grada; Yang Yang; Xiaoqiang Wu; Gweneth Levy; Eliza M. Raymundo; Henrique D. Teixeira; Jonathan I. Silverberg
err分享
err收藏
From Disease Control to Disease Modification: The Atopic Dermatitis Disease Activity Index从疾病控制到疾病修饰：特应性皮炎疾病活动度指数
errAllergy
IF12
err2025-08-29
err0
errOAAI
errThomas Bieber; Laura Maintz; Ganesh E. Phad; Marie-Charlotte Brüggen
err分享
err收藏
Die ADVANCE PN Studie: was können wir daraus lernen?ADVANCE PN研究：我们能从中得到什么启示？
errjournal der deutschen dermatologischen gesellschaft
IF0
err2025-07-14
err0
PREAI
errThomas Bieber
err分享
err收藏
Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications更正：Baricitinib在风险人群中特殊兴趣事件的安全性：来自风湿病学和皮肤病学适应症随机试验数据分析
errAdvances in Therapy
IF4
err2025-07-11
err0
errOAAI
errPeter C. Taylor; Thomas Bieber; Rieke Alten; Torsten Witte; James Galloway; Walter Deberdt; Maher Issa; Ewa Haladyj; Inmaculada De La Torre; Susanne Grond; Andreas Wollenberg
err分享
err收藏
Langerhans Cell Modulation in Atopic Dermatitis Is TLR2/SOCS1-Dependent and JAK Inhibitor-Sensitive特应性皮炎中朗格汉斯细胞的调控依赖于TLR2/SOCS1，且对JAK抑制剂敏感。
errAllergy
IF12
err2025-07-09
err0
errOAAI
errYuxuan Deng; Nicole Leib; Sylvia Schnautz; Said Benfadal; Johannes Oldenburg; Thomas Bieber; Nadine Herrmann
err分享
err收藏
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy
errDERMATOLOGY AND THERAPY
IF4.2
err2025-02-14
err2
errOAAI
errSilverberg, Jonathan I.; Bieber, Thomas; Paller, Amy S.; Beck, Lisa; Kamata, Masahiro; Puig, Luis; Wiseman, Marni; Ezzedine, Khaled; Irvine, Alan D.; Foley, Peter; Del Rosso, James; Gold, Linda Stein; Johansson, Erin; Dossenbach, Martin; Gallo, Gaia; Akmaz, Buelent; Casillas, Marta; Karlsson, Andrei; Curteis, Tristan; Chovatiya, Raj
err分享
err收藏
The paradigm shift in drug development for atopic dermatitis: Addressing the variables of the equation leading to disease modification特应性皮炎药物开发范式的转变：解决导致疾病修饰的方程变量
errANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
IF4.7
err2025-02-01
err3
errOAAI
errBieber, T
err分享
err收藏
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)( Sept, 10.1007/s12325-024-02974-y, 2024)在特应性皮炎中使用Lebrikizumab改善疾病的各个方面: 两项3期，随机，双盲，安慰剂对照的单一疗法试验 (ADvocate1和ADvocate2)(2024，10.1007/s12325-024-02974-y，9月)
errADVANCES IN THERAPY
IF4
err2024-12-05
err0
errOAAI
errSimpson, Eric; Fernandez-Penas, Pablo; de Bruin-Weller, Marjolein; Lio, Peter A.; Chu, Chia-Yu; Ezzedine, Khaled; Agell, Helena; Casillas, Marta; Ding, Yuxin; Yang, Fan Emily; Pierce, Evangeline; Bieber, Thomas
err分享
err收藏
The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials
errJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
err2024-12-01
err0
PREAI
errGuttman-Yassky, Emma; Rosmarin, David; de Bruin-Weller, Marjolein; Weidinger, Stephan; Bieber, Thomas; Hong, H. Chih-ho; Elmaraghy, Hany; Atwater, Amber Reck; Pierce, Evangeline; Xu, Chenjia; Agell, Helena; Gil, Esther Garcia; Simpson, Eric
err分享
err收藏
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials
errNATURE COMMUNICATIONS
IF15.7
err2024-10-25
err0
errOAAI
errSilverberg, Jonathan I.; Rosmarin, David; Chovatiya, Raj; Bieber, Thomas; Schleicher, Stephen; Beck, Lisa; Gooderham, Melinda; Chaudhry, Sohail; Fanton, Christie; Yu, Danni; Levy, Joshua; Liu, Yi; Miyazaki, Takahiro; Tagliaferri, Mary; Schmitz, Carsten; Nirula, Ajay; Kotzin, Brian; Zalevsky, Jonathan
err分享
err收藏
Emerging Biologic Therapies for the Treatment of Atopic Dermatitis治疗特应性皮炎的新兴生物制剂
errDRUGS
IF14.4
err2024-10-04
err1
errOAAI
errAlvarenga, Jose Miguel; Bieber, Thomas; Torres, Tiago
err分享
err收藏
Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis
errJAMA DERMATOLOGY
IF11
err2024-10-01
err0
PREAI
errDErme, Angelo Massimiliano; Fidanzi, Cristian; Bevilacqua, Matteo; Bieber, Thomas; Tuoni, Cristina; Paolicchi, Aldo; Franzini, Maria; Morganti, Riccardo; Papadia, Francesca; Janowska, Agata; Dini, Valentina; Romanelli, Marco
err分享
err收藏
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2)在特应性皮炎中使用Lebrikizumab改善疾病的各个方面: 两项3期，随机，双盲，安慰剂对照的单一疗法试验 (ADvocate1和ADvocate2)
errADVANCES IN THERAPY
IF4
err2024-09-09
err0
errOAAI
errSimpson, Eric; Fernandez-Penas, Pablo; de Bruin-Weller, Marjolein; Lio, Peter A.; Chu, Chia-Yu; Ezzedine, Khaled; Agell, Helena; Casillas, Marta; Ding, Yuxin; Yang, Fan Emily; Pierce, Evangeline; Bieber, Thomas
err分享
err收藏
Will deciphering the epidermal 'ménage à trois' lead to predictive biomarkers for childhood atopic dermatitis?破译表皮 “m é nage à trois” 会导致儿童特应性皮炎的预测生物标志物吗？
errJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
err2024-08-23
err0
errOAAI
errBieber, Thomas
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
M
Marc Humbert
H 指数: 177 · 论文数: 2.2K
C
Cezmi A. Akdiş
H 指数: 153 · 论文数: 1.1K
R
Richard L. Gallo
H 指数: 148 · 论文数: 885
J
Joachim Heinrich
H 指数: 147 · 论文数: 1.5K
D
Donald Y.M. Leung
H 指数: 135 · 论文数: 1.2K
查看更多